Viewing Study NCT01775358


Ignite Creation Date: 2025-12-25 @ 12:01 AM
Ignite Modification Date: 2026-05-23 @ 10:54 PM
Study NCT ID: NCT01775358
Status: COMPLETED
Last Update Posted: 2013-05-30
First Post: 2013-01-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Safety Study of ALRN-5281 in Healthy Subjects
Sponsor: Aileron Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Growth Hormone Deficiency View
Keywords: